Last reviewed · How we verify

NCT06744478

Assessing the Magnitude of Anisometropia in Patients Wearing Misight 1 Day Contact Lens

ENROLLING BY INVITATION Last updated 20 December 2024
What this trial tests

trial testing Misight 1 Day Contact Lens in Myopia in 50 participants. Enrolling by invitation.

Timeline
1 January 2025
Primary endpoint
31 December 2025
31 December 2026

Quick facts

Lead sponsorBuddhist Tzu Chi General Hospital
StatusENROLLING BY INVITATION
Study typeOBSERVATIONAL
Enrollment50
Start date1 January 2025
Primary completion31 December 2025
Estimated completion31 December 2026
Sites1 location across Taiwan

Drugs / interventions tested

Conditions studied

Sponsor

Buddhist Tzu Chi General Hospital

Who can join

Adults 8 to 23, any sex, with Myopia or Anisometropia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The effectiveness of Misight 1 Day Contact Lens in retarding anisometropic progression has not been investigated before. This study is aimed to elucidate the efficacy of Misight 1 Day Contact Lens for anisometropia control.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Myopia

Currently open trials in the same condition.

Other Buddhist Tzu Chi General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06744478.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing